The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Pancreatic β Cell Dedifferentiation in Diabetes and Redifferentiation following Insulin Therapy
Open accessAbstract
Diabetes is characterized by ‘glucotoxic’ loss of pancreatic β-cell function and insulin content, but underlying mechanisms remain unclear. A mouse model of insulin-secretory deficiency induced by β-cell inexcitability (KATP gain-of-function) demonstrates development of diabetes and reiterates the features of human neonatal diabetes. In the diabetic state, β-cells lose their mature identity and dedifferentiate to neurogenin3-positive and insulin-negative cells. Lineage-tracing experiments show that dedifferentiated cells can subsequently re-differentiate to mature neurogenin3-negative, insulin-positive, β-cells after lowering of blood glucose by insulin therapy. We demonstrate here that β-cell dedifferentiation, rather than apoptosis, is the main mechanism of loss of insulin-positive cells, and re-differentiation accounts for restoration of insulin content and antidiabetic-drug responsivity in these animals. These results may help explain gradual decrease in β-cell mass in long-standing diabetes, and recovery of β-cell function and drug responsivity in type-2 diabetic patients following insulin therapy, and suggest an approach to rescuing ‘exhausted’ β-cells in diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Islet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690 · cited 2×
“Type 2 diabetes is characterized by b cell dysfunction, the mechanism of which is controversial (Ahlqvist et al., 2011; Butler et al., 2003; Hur et al., 2010; Nolan and Prentki, 2008; Prentki and Nolan, 2006; Puri and Hebrok, 2012; Robertson et al., 2004; Talchai et al., 2012b; Wajchenberg, 2007).”
Gu, G., Dubauskaite, J., & Melton, D. A. (2002) · Development · doi:10.1242/dev.129.10.2447 · Cited by 1,518
Mechanisms of Pancreatic β-Cell Death in Type 1 and Type 2 Diabetes
Cnop, M., Welsh, N., Jonas, J.-C., Jörns, A., Lenzen, S., & Eizirik, D. L. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s97 · Cited by 1,491
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Talchai, C., Xuan, S., Lin, H. V., Sussel, L., & Accili, D. (2012) · Cell · doi:10.1016/j.cell.2012.07.029 · Cited by 1,415
Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032922 · Cited by 1,137
Glucolipotoxicity: fuel excess and β-cell dysfunction
Poitout, V., & Robertson, R. P. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0023 · Cited by 1,092
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
β Cells Can Be Generated from Endogenous Progenitors in Injured Adult Mouse Pancreas
Xu, X., D'Hoker, J., Stangé, G., Bonné, S., De Leu, N., Xiao, X., Van De Casteele, M., Mellitzer, G., Ling, Z., Pipeleers, D., et al. (2008) · Cell · doi:10.1016/j.cell.2007.12.015 · Cited by 988
Type 2 diabetes across generations: from pathophysiology to prevention and management
Nolan, C. J., Damm, P., & Prentki, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60614-4 · Cited by 923
β-Cell Glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes.
Robertson, R. P., Harmon, J., Tran, P. O. T., & Poitout, V. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s119 · Cited by 914
Type 2 Diabetes-a Matter of ß-Cell Life and Death?
Rhodes, C. J. (2005) · Science · doi:10.1126/science.1104345 · Cited by 896
Weng, J., Li, Y., Xu, W., Shi, L., Zhang, Q., Zhu, D., Hu, Y., Zhou, Z., Yan, X., Tian, H., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60762-x · Cited by 780
Pancreatic β‐cell mass in European subjects with type 2 diabetes
Rahier, J., Guiot, Y., Goebbels, R. M., Sempoux, C., & Henquin, J. C. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00969.x · Cited by 756
β-Cell Failure in Diabetes and Preservation by Clinical Treatment
Wajchenberg, B. L. (2007) · Endocrine Reviews · doi:10.1210/10.1210/er.2006-0038 · Cited by 714
Sakuraba, H., Mizukami, H., Yagihashi, N., Wada, R., Hanyu, C., & Yagihashi, S. (2002) · Diabetologia · doi:10.1007/s125-002-8248-z · Cited by 681
Jonas, J.-C., Sharma, A., Hasenkamp, W., Ilkova, H., Patanè, G., Laybutt, R., Bonner-Weir, S., & Weir, G. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.14112 · Cited by 559
FoxO1 protects against pancreatic β cell failure through NeuroD and MafA induction
Kitamura, Y. I., Kitamura, T., Kruse, J.-P., Raum, J. C., Stein, R., Gu, W., & Accili, D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.08.004 · Cited by 556
cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2
Jhala, U. S., Canettieri, G., Screaton, R. A., Kulkarni, R. N., Krajewski, S., Reed, J., Walker, J., Lin, X., White, M., & Montminy, M. (2003) · Genes & Development · doi:10.1101/gad.1097103 · Cited by 543
Inactivation of specific β cell transcription factors in type 2 diabetes
Guo, S., Dai, C., Guo, M., Taylor, B., Harmon, J. S., Sander, M., Robertson, R. P., Powers, A. C., & Stein, R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65390 · Cited by 520
Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function
Heit, J. J., Apelqvist, Å. A., Gu, X., Winslow, M. M., Neilson, J. R., Crabtree, G. R., & Kim, S. K. (2006) · Nature · doi:10.1038/nature05097 · Cited by 444
Tanaka, Y., Tran, P. O. T., Harmon, J., & Robertson, R. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192445199 · Cited by 315
Control of Pancreatic β Cell Regeneration by Glucose Metabolism
Porat, S., Weinberg-Corem, N., Tornovsky-Babaey, S., Schyr-Ben-Haroush, R., Hija, A., Stolovich-Rain, M., Dadon, D., Granot, Z., Ben-Hur, V., White, P., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.012 · Cited by 298
Nielsen, E.-M. D., Hansen, L., Carstensen, B., Echwald, S. M., Drivsholm, T., Glümer, C., Thorsteinsson, B., Borch-Johnsen, K., Hansen, T., & Pedersen, O. (2003) · Diabetes · doi:10.2337/diabetes.52.2.573 · Cited by 288
Ilkova, H., Glaser, B., Tunçkale, A., Bagriaçik, N., & Cerasi, E. (1997) · Diabetes Care · doi:10.2337/diacare.20.9.1353 · Cited by 269
The replication of β cells in normal physiology, in disease and for therapy
Butler, P. C., Meier, J. J., Butler, A. E., & Bhushan, A. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0647 · Cited by 268
Flanagan, S. E., Clauin, S., Bellanné-Chantelot, C., de Lonlay, P., Harries, L. W., Gloyn, A. L., & Ellard, S. (2009) · Human Mutation · doi:10.1002/humu.20838 · Cited by 241
Alvarsson, M., Sundkvist, G., Lager, I., Henricsson, M., Berntorp, K., Fernqvist-Forbes, E., Steen, L., Westermark, G., Westermark, P., Örn, T., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2231 · Cited by 170
Generation of functional insulin-producing cells in the gut by Foxo1 ablation
Talchai, C., Xuan, S., Kitamura, T., DePinho, R. A., & Accili, D. (2012) · Nature Genetics · doi:10.1038/ng.2215 · Cited by 168
Ahlqvist, E., Ahluwalia, T. S., & Groop, L. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.157016 · Cited by 166
Wang, S., Jensen, J. N., Seymour, P. A., Hsu, W., Dor, Y., Sander, M., Magnuson, M. A., Serup, P., & Gu, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904247106 · Cited by 160
Critical Reduction in β-Cell Mass Results in Two Distinct Outcomes over Time
Laybutt, D. R., Glandt, M., Xu, G., Ahn, Y. B., Trivedi, N., Bonner‐Weir, S., & Weir, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210581200 · Cited by 157
The islet β-cell: fuel responsive and vulnerable
Nolan, C. J., & Prentki, M. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.07.006 · Cited by 157
Type 2 Diabetes, Insulin Secretion and β-Cell Mass
Ahren, B. (2005) · Current Molecular Medicine · doi:10.2174/1566524053766004 · Cited by 143
Glucose regulation of islet stress responses and β‐cell failure in type 2 diabetes
Jonas, J., Bensellam, M., Duprez, J., Elouil, H., Guiot, Y., & Pascal, S. M. A. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01112.x · Cited by 143
Tamoxifen-Induced Cre-loxP Recombination Is Prolonged in Pancreatic Islets of Adult Mice
Reinert, R. B., Kantz, J., Misfeldt, A. A., Poffenberger, G., GANNON, M. A., Briššová, M., & Powers, A. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033529 · Cited by 141
Weinberg-Corem, N., Ouziel-Yahalom, L., Knoller, S., Efrat, S., & Dor, Y. (2007) · Diabetes · doi:10.2337/db06-1654 · Cited by 140
IMPROVEMENT IN INSULIN SECRETION IN DIABETES AFTER DIAZOXIDE
Greenwood, R. H., Mahler, R., & Hales, C. N. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91473-2 · Cited by 118
A novel mutation causing DEND syndrome
Shimomura, K., Hörster, F., de Wet, H., Flanagan, S. E., Ellard, S., Hattersley, A. T., Wolf, N. I., Ashcroft, F. M., & Ebinger, F. (2007) · Neurology · doi:10.1212/01.wnl.0000268488.51776.53 · Cited by 114
ß‐cell function and anti‐diabetic pharmacotherapy
Prato, S. D., Bianchi, C., & Marchetti, P. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.770 · Cited by 107
Girard, C. A., Wunderlich, F. T., Shimomura, K., Collins, S., Kaizik, S., Proks, P., Abdulkader, F., Clark, A., Ball, V., Zubcevic, L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35772 · Cited by 105
Remedi, M. S., Kurata, H. T., Scott, A. C., Wunderlich, F. T., Rother, E., Kleinridders, A., Tong, A., Brüning, J. C., Koster, J. C., & Nichols, C. G. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.005 · Cited by 94
Self-citationChronic Antidiabetic Sulfonylureas In Vivo: Reversible Effects on Mouse Pancreatic β-Cells
Remedi, M. S., & Nichols, C. G. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050206 · Cited by 93
Self-citationβ-cell apoptosis in type 2 diabetes: quantitative and functional consequences
Lupi, R., & Prato, S. D. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)73396-2 · Cited by 90
Villareal, D. T., Koster, J. C., Robertson, H., Akrouh, A., Miyake, K., Bell, G. I., Patterson, B. W., Nichols, C. G., & Polonsky, K. S. (2009) · Diabetes · doi:10.2337/db09-0025 · Cited by 83
Self-citationCurrent status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes
Riedel, M. J., Steckley, D., & Light, P. E. (2004) · Human Genetics · doi:10.1007/s00439-004-1216-5 · Cited by 80
Bernal‐Mizrachi, E., Wice, B. M., Inoue, H., & Permutt, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003424200 · Cited by 63
Role of autophagy in β ‐cell function and mass
Hur, K. Y., Jung, H. S., & Lee, M. ‐. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01278.x · Cited by 61
Alvarsson, M., Sundkvist, G., Lager, I., Berntorp, K. E., Fernqvist‐Forbes, E., Steen, L., Örn, T., Holberg, M. A., Kirksæther, N., & Grill, V. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00719.x · Cited by 60
Benninger, R. K. P., Remedi, M. S., Head, W. S., Ustione, A., Piston, D. W., & Nichols, C. G. (2011) · Diabetologia · doi:10.1007/s00125-010-2039-7 · Cited by 37
Self-citationThe diabetic β‐cell: hyperstimulated vs. hyperexcited
Nichols, C. G., & Remedi, M. S. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01655.x · Cited by 36
Self-citationAcute Sulfonylurea Therapy at Disease Onset Can Cause Permanent Remission of KATP-Induced Diabetes
Remedi, M. S., Agapova, S. E., Vyas, A. K., Hruz, P. W., & Nichols, C. G. (2011) · Diabetes · doi:10.2337/db11-0538 · Cited by 36
Self-citationQvigstad, E., Kollind, M., & Grill, V. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01091.x · Cited by 30
Diabetic β Cells: To Be or Not To Be?
Puri, S., & Hebrok, M. (2012) · Cell · doi:10.1016/j.cell.2012.08.021 · Cited by 29
Torella, R., Salvatore, T., Cozzolino, D., Giunta, R. E., Quatraro, A., & Giugliano, D. (1991) · PubMed · Cited by 13
UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years
UK Prospective Diabetes Study (UKPDS) Group, Matthews, D. R., Cull, C. A., Stratton, I. M., Holman, R. R., & Turner, R. C. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199804)15:4
Cited by
Animal models of obesity and diabetes mellitus
Kleinert, M., Clemmensen, C., Hofmann, S. M., Moore, M. C., Renner, S., Woods, S. C., Huypens, P., Beckers, J., de Angelis, M. H., Schürmann, A., et al. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.161 · Cited by 832
Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men
Rorsman, P., & Ashcroft, F. M. (2018) · Physiological Reviews · doi:10.1152/physrev.00008.2017 · Cited by 793
Mechanisms controlling pancreatic islet cell function in insulin secretion
Campbell, J. E., & Newgard, C. B. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00317-7 · Cited by 629
Lawlor, N., George, J., Bolisetty, M., Kursawe, R., Sun, L., Sivakamasundari, V., Kycia, I., Robson, P., & Stitzel, M. L. (2017) · Genome Research · doi:10.1101/gr.212720.116 · Cited by 562
Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes
Cinti, F., Bouchi, R., Kim-Muller, J. Y., Ohmura, Y., Sandoval, P. R., Masini, M., Marselli, L., Suleiman, M., Ratner, L. E., Marchetti, P., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2860 · Cited by 550
Metadata
- Authors
- Wang, Z., York, N. W., Nichols, C. G., & Remedi, M. S.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 19
- Issue
- 5
- Pages
- 872-882
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2046438754
- Cited by
- 406
- References
- 60
- FWCI
- 34.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.